These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2509683)

  • 21. Cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs and gastric mucosal responses.
    Takeuchi K; Suzuki K; Yamamoto H; Araki H; Mizoguchi H; Ukawa H
    J Physiol Pharmacol; 1998 Dec; 49(4):501-13. PubMed ID: 10069692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastric effects of a prostaglandin E1-derivate (rioprostil) on acid, alkaline, and mucus secretion.
    Guslandi M; Passaretti S; Tittobello A; Fasani R
    Clin Ther; 1986; 8(6):619-23. PubMed ID: 3098425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rioprostil and the gastric mucus-bicarbonate barrier.
    Guslandi M; Fasani R; Tittobello A
    Scand J Gastroenterol Suppl; 1989; 164():92-5; discussion 95-6. PubMed ID: 2510287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of the prostaglandin E1 analogue Rioprostil on the human gastric mucosa.
    Svendsen LB; Stener Jørgensen F; Hart Hansen O; Johansen A; Horn T; Larsen JK
    Digestion; 1987; 37(1):29-34. PubMed ID: 3111919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of chronic rioprostil treatment on gastric endocrine function.
    Koop H; Schwarting H; Eckel U; Wagenknecht J; Hallfeldt U; Arnold R
    Scand J Gastroenterol Suppl; 1989; 164():104-10; discussion 110-1. PubMed ID: 2573147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Misoprostol attenuates aspirin-induced changes in potential difference and associated damage in canine gastric mucosa.
    Gullikson GW; Anglin CP; Kessler LK; Smeach S; Bauer RF; Dajani EZ
    Clin Invest Med; 1987 May; 10(3):145-51. PubMed ID: 3113798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of prostaglandins in gastroprotection and gastric adaptation.
    Brzozowski T; Konturek PC; Konturek SJ; Brzozowska I; Pawlik T
    J Physiol Pharmacol; 2005 Sep; 56 Suppl 5():33-55. PubMed ID: 16247188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostaglandins and peptic ulcer disease: nocturnal administration of rioprostil vs ranitidine in duodenal ulcer healing.
    Simon B; Dammann HG; Müller P
    Klin Wochenschr; 1986; 64 Suppl 7():44-6. PubMed ID: 3104657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinction between antiulcer effect and cytoprotection.
    Robert A; Lancaster C; Davis JP; Field SO; Nezamis JE
    Scand J Gastroenterol Suppl; 1984; 101():69-73. PubMed ID: 6599540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gastric antisecretory and antiulcer properties of enprostil, (+/-)-11 alpha, 15 alpha-dihydroxy-16-phenoxy-17,18,19,20-tetranor-9-oxoprosta- 4,5,13(t)-trienoic acid methyl ester.
    Roszkowski AP; Garay GL; Baker S; Schuler M; Carter H
    J Pharmacol Exp Ther; 1986 Nov; 239(2):382-9. PubMed ID: 3095537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of trimoprostil on gastric secretion in man.
    Ishimori A; Kawamura T; Koizumi F
    Arzneimittelforschung; 1988 Jun; 38(6):833-9. PubMed ID: 3140824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of rioprostil, 600 micrograms, on the interdigestive myoelectrical activity of the humans small intestine.
    Vantrappen G; Janssens J
    Scand J Gastroenterol Suppl; 1989; 164():133-8; discussion 138-9. PubMed ID: 2510257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-ulcer effect of 3-[p-(trans-4-aminomethylcyclohexylcarbonyl) phenyl] propionic acid hydrochloride (TEI-5103).
    Hoshina K; Yamazaki N; Takeshita T; Naruchi T
    Arzneimittelforschung; 1985; 35(2):493-7. PubMed ID: 3873243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of aspirin-induced gastric mucosal injury by histamine H2 receptor antagonists: a crossover endoscopic and intragastric pH study in the dog.
    Cavanagh RL; Buyniski JP; Schwartz SE
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1179-84. PubMed ID: 2891837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The therapeutic efficacy of misoprostol in peptic ulcer disease.
    Watkinson G; Hopkins A; Akbar FA
    Postgrad Med J; 1988; 64 Suppl 1():60-77. PubMed ID: 3138682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytoprotective effect of sofalcone in the rat gastric mucosa.
    Isobe Y; Hirose H; Muramatsu M; Aihara H
    Arzneimittelforschung; 1985; 35(1):138-41. PubMed ID: 3857044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiulcer effect of rioprostil, a prostaglandin E1 analog, in combination with antacid.
    Katz LB; Genna T; Shriver DA
    Life Sci; 1986 Sep; 39(11):1013-9. PubMed ID: 3091974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nitric oxide (NO)-releasing naproxen (HCT-3012 [(S)-6-methoxy-alpha-methyl-2-naphthaleneacetic Acid 4-(nitrooxy)butyl ester]) interactions with aspirin in gastric mucosa of arthritic rats reveal a role for aspirin-triggered lipoxin, prostaglandins, and NO in gastric protection.
    Fiorucci S; Di Lorenzo A; Renga B; Farneti S; Morelli A; Cirino G
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1264-71. PubMed ID: 15297470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of rioprostil on gastric acid and pepsin secretion in man: a review of studies in healthy volunteers.
    Demol P; Singer MV; Dammann HG; Richardson CT; Weihrauch TR
    Scand J Gastroenterol Suppl; 1989; 164():74-9; discussion 79-80. PubMed ID: 2510285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rioprostil, a new prostaglandin E1 analogue does not affect glucose homeostasis in healthy volunteers.
    Eichler HG; Korn A; Businger JA; Waldhäusl WK
    Arch Int Pharmacodyn Ther; 1989; 298():288-92. PubMed ID: 2502955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.